Hereditary in Biological Technology

ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema

... [human]) as a treatment for acute attacks of hereditary angioedema (HAE). The FDA has requested an ... Castaldo, president of the U.S. and International hereditary Angioedema Association. "Cinryze as a ... an injection rate of 1 mL per minute. About hereditary Angioedema (HAE) HAE is a rare, severely ...

ViroPharma Incorporated Honored by the National Organization for Rare Disorders

... to market for a rare and devastating disorder -- hereditary angioedema (HAE). HAE is a rare, severely ... injection rate of 1 mL per minute. About hereditary Angioedema HAE is a rare, severely ... attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor ...

Waters Corporation Gives Boost to Clinical Research Programs at University of Sherbrooke Hospital

... and assessment of treatments for specific hereditary diseases, as well as for patient surveillance and ... at the cutting edge of genetics in detecting hereditary metabolic diseases and in research into assessing ... well as other devices dedicated to screening for hereditary diseases (mass spectrometers), surgical and ...

ViroPharma To Acquire Lev Pharmaceuticals

... Late Stage Product Targeting Life-threatening hereditary Angioedema Disease with Limited ... as a replacement therapy for patients with hereditary angioedema (HAE), also known as C1 esterase ... number of other serious inflammatory disorders. hereditary angioedema, or C1-INH deficiency, is a dangerous ...

Otonomy Introduces Scientific Advisory Board

... Friedman, M.D., Ph.D. Dr. Friedman is the research section chief of hereditary ear disorders in the department of Cell and Molecular Biology at the House ... and St. Vincent Medical Center. His area of expertise is the study of hereditary deafness. Dr. Friedman served as a resident in the division of ...

Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin'

... a physician to have them re-evaluated. Nasal allergies can be hereditary : If parents have indoor or outdoor allergies, it is possible that their children will also. Nasal allergies tend to be hereditary -- although the exact genetic factors are not fully understood. ...

ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results

... Initiated commercial launch of Cinryze for routine prophylaxis of hereditary angioedema (HAE); Developed and successfully launched Cinryze ... against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... alfa free of charge initially, in order to provide access to patients as quickly as possible. FIRAZYR(R) - for the treatment of hereditary angioedema ("HAE") - In June 2009, Shire initiated a Phase 3 study in patients with acute attacks of HAE, known as the FAST-3 trial, which is ...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

... of Prostate Cancer II-27 TNM Staging II-27 T-Staging Analysis of Prostate Cancer II-27 Genetic & Non-Genetic Factors II-28 hereditary or Genetic Factors II-28 Non-Genetic or Environmental Factors II-28 Table 17: Prostate Cancer Incidence/Mortality Rate by Race & ...

Fruit fly steps in to fight human disease

... and the Katholieke Universiteit Leuven, and appears in the Proceedings of the National Academy of Sciences (PNAS). Charcot-Marie-Tooth is a hereditary disorder of the peripheral nervous system that affects 1 in 2,500 people worldwide. Patients suffer from progressive motor impairment, muscle wasting ...

Video: Varicose Veins, Much More Than a Cosmetic Issue, Can Prove a Health Risk

... own needs for last. My work as a nurse has taught me to look for signs from my body, and in the bodies of patients, and to keep special track of the hereditary diseases such as varicose veins," said Iliana Portela, Registered Nurse with Vein Clinics of America. "To be the strong support our family needs, ...

ViroPharma to Present at Two June Healthcare Conferences

... commercializes Cinryze(TM) (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package ...

ViroPharma Incorporated Reports First Quarter 2009 Financial Results

... commercializes Cinryze(TM) (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package ...

ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009

... strains, and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package ...

Publication of Shire plc's Annual Report 2008

... pre-clinical development for the Specialty Pharmaceuticals area. Human Genetic Therapies Treatments for Angioedema FIRAZYR for hereditary angioedema ('HAE') in the US FIRAZYR is a treatment for acute HAE which Shire added to the portfolio through its acquisition of a majority ...

ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes

... strains, and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package ...

EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention

... for comprehensive information and education on age-related macular degeneration (AMD) in a unique watch-and-learn video format. AMD is a progressive, hereditary eye disease that is the leading cause of blindness in Americans age 50 or older. On the site, visitors can learn about basic eye anatomy, ...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

... and Mylan, and under the Hatch Waxman Act has 45 days to determine if it will file patent infringement suits. Pipeline FIRAZYR - for hereditary angioedema ("HAE") in the US - In December 2008 Jerini AG ("Jerini") met with the US Food and Drug Administration ("FDA") to discuss the ...

Chronic Lung Disease - Axentis Pharma Attracts Investment Interest

... of the microbial cell, which leads to rapid cell death. About cystic fibrosis Cystic fibrosis is the most common life-threatening hereditary disease amongst Caucasian populations. The disease is caused by a mutation in the CFTR (cystic fibrosis transmembrane conductance regulator) gene ...

Confirmation of HGT Business Day - 18th November 2008

... senior team. In addition, Shire is pleased to announce that Pr. Marco Cicardi, M.D. University of Milan and Specialist in Angioedema will present on hereditary Angioedema. Notes to editors Shire Plc Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on ...

Shire's New Product Portfolio Delivers Strong Quarterly Performance

... Commission. Launches will continue across Europe as reimbursement negotiations proceed. FIRAZYR has orphan designation and is the first hereditary angiodema ("HAE") product to receive approval throughout the European Union; - INTUNIV(TM) (guanfacine) for use in children and adolescents ...

Researchers develop new model for cystic fibrosis

... of the disease and may also speed discovery of new treatments. The study is published in the Sept. 26 issue of Science. CF is a common hereditary disease that affects multiple organ systems, including the intestines, pancreas, and lung. Mice with CF-causing mutations have helped researchers ...

Video: Moms Raise 'Red Flag' About the Dangers of Widely Undiagnosed Bleeding Disorder

... Willebrand Disease NEW YORK, Sept. 23 /PRNewswire/ -- While an estimated 2.8 million Americans are affected by the most common hereditary bleeding disorder, von Willebrand disease (VWD), most don't even know they have it. VWD affects both men and women, but according to the Centers for ...

Abeome Forms First Class Scientific Advisory Board

... Cancer Scholar by the Georgia Cancer Coalition. His long-term research focus has studied molecular genetics of ovarian cancer with emphasis on hereditary predisposition. Linda Matsuuchi, PhD, Associate Director of the Life Sciences Institute at the University of British Columbia, has a distinguished ...

Video: CSL Behring Provides $1.2M Grant for World's First Study of Postpartum Women with VWD, Common Bleeding Disorder

... To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/cslbehring/32474/ Von Willebrand disease (VWD) is the most common hereditary bleeding disorder in the United States, and is caused by a deficiency or abnormality of von Willebrand factor in the blood. According to the U.S. ...

Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.

... of certain customary terms and conditions, including approval by relevant merger control authorities. The proposed acquisition will add Jerini's hereditary angioedema ("HAE") product, FIRAZYR(R) (icatibant), (expected to be launched in the EU in H2 2008) to Shire's Human Genetic Therapies ("HGT") ...

Incorrectly cleaved protein leads to schizophrenia

... delusions, hallucinations, chaotic behavior, etc. The origin of the disease Up to now, no clear cause of schizophrenia has been found, although hereditary factors certainly play a role in the development of the disease. In addition, living and working conditions determine the disorder's progress. ...

Cystic Fibrosis - Axentis Pharma Takes Over Patents and Continues Development of Innovative Platform Technology

... and investors extensive prospects for the treatment of this disease." About cystic fibrosis Cystic fibrosis is the most common life-threatening hereditary disease among Caucasian population. The disease is caused by a mutation in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene found ...

Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia

... food 2 hours before and 1 hour after taking dose. Lactose Since the capsules contain lactose, Tasigna is not recommended for patients with rare hereditary problems of galactose intolerance, severe lactase deficiency, or of glucose-galactose malabsorption. Pregnancy Fetal harm can occur when Tasigna ...

Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntington's Disease

... Raptor's clinical development subsidiary, Bennu Pharmaceuticals Inc. ("Bennu"), plans to evaluate cysteamine in patients with HD. HD is a rare and hereditary neurological disease thought to occur in approximately 1 out of every 20,000 people resulting in around 20,000 patients in the U.S. presently. There ...

CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies

... clotting factors (Factor VIII). Hemophilia A (often called classic hemophilia) accounts for about 80% of all hemophilia cases. Hemophilia A is a hereditary disorder in which the clotting ability of the blood is impaired and excessive bleeding results. Small wounds and punctures are usually not a problem, ...

Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market

... for the hemostasis laboratory. This test represents a differentiated continuation of our menu expansion program." FII and FV are the most common hereditary risk factors for venous thrombosis and are key in the determination of genetic predisposition to the condition and the need for prophylactic ...

Cord Blood America CEO Matthew Schissler Interviewed by BIONOVA, Greece's Leading Biotech Magazine

... in the treatment of leukemia, breast cancer, lymphoma, Hodgkin's Disease, aplastic anemia, sickle cell anemia, various other cancers, blood diseases, hereditary and genetic conditions and immune system disorders," Mr. Schissler said in the interview. "As stem cell transplants become routine, they may be used ...

CSL Behring Expands Into Middle East Market with Haemate(R) P

... High levels of Type III von Willebrand Disease, a serious, hereditary bleeding disorder, found in region KING OF PRUSSIA, Pa., Dec. 19 /PRNewswire/ -- CSL Behring today announced that Iran's Ministry ...

Exelixis Submits XL880 Diligence Report to GlaxoSmithKline

... studies, XL880 inhibited its targets with nanomolar potency, and retained potent activity against mutationally activated forms of MET found in hereditary papillary renal cell carcinomas. The compound also demonstrated dose-dependent tumor growth inhibition in models of breast cancer, colorectal cancer, ...

European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera

... its lead compound, SNT-MC17 (INN: idebenone), in the treatment of Friedreich's Ataxia (FRDA), Duchenne Muscular Dystrophy (DMD) and Leber's hereditary Optic Neuropathy (LHON). Another clinical program is investigating JP-1730 (INN: fipamezole) for the treatment of Dyskinesia in Parkinson's Disease ...

Rice Centromere, Supposedly Quiet Genetic Domain, Surprises

... the scientific understanding of chromosomes, the molecular structures that are found in all animal and plant cells, and are the essential carriers of hereditary information, enabling the processes of cell division and replication. At a practical level, the work is a necessary step toward science's ...

Children's Hospital chooses Camtronics for cardiology IT system

... system CardioIMS. The system will be implemented in the Columbus Children's Heart Center , which addresses the needs of children and adults with hereditary heart defects. The choice was based on an in-depth study of the Center's administrative and clinical needs, looking specifically at the issue of ...

Third Wave to seek FDA clearences after expanding pipeline

... over some key management positions. Read more here. Third Wave expects to seek FDA clearance for in-vitro diagnostics for Factor V Leiden, a hereditary blood disease, and Factor II prothrombin deficiency, a form of hemophilia. The company said the products are already on the market, but FDA clearance ...